"Tuberculosis, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
MYCOBACTERIUM infections of the lung.
| Descriptor ID |
D014397
|
| MeSH Number(s) |
C01.252.410.040.552.846.899 C08.381.922 C08.730.939
|
| Concept/Terms |
Tuberculosis, Pulmonary- Tuberculosis, Pulmonary
- Tuberculoses, Pulmonary
- Pulmonary Tuberculoses
- Pulmonary Tuberculosis
- Pulmonary Consumption
- Consumption, Pulmonary
- Consumptions, Pulmonary
- Pulmonary Consumptions
- Pulmonary Phthisis
- Phthises, Pulmonary
- Phthisis, Pulmonary
- Pulmonary Phthises
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis, Pulmonary".
This graph shows the total number of publications written about "Tuberculosis, Pulmonary" by people in this website by year, and whether "Tuberculosis, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 6 | 1 | 7 |
| 1996 | 3 | 0 | 3 |
| 1997 | 0 | 1 | 1 |
| 1999 | 5 | 0 | 5 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 1 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 4 | 3 | 7 |
| 2004 | 6 | 1 | 7 |
| 2005 | 6 | 1 | 7 |
| 2006 | 5 | 4 | 9 |
| 2007 | 4 | 0 | 4 |
| 2008 | 4 | 0 | 4 |
| 2009 | 4 | 0 | 4 |
| 2010 | 1 | 1 | 2 |
| 2011 | 5 | 0 | 5 |
| 2012 | 6 | 0 | 6 |
| 2013 | 7 | 0 | 7 |
| 2014 | 10 | 0 | 10 |
| 2015 | 10 | 1 | 11 |
| 2016 | 13 | 2 | 15 |
| 2017 | 8 | 4 | 12 |
| 2018 | 6 | 1 | 7 |
| 2019 | 3 | 3 | 6 |
| 2020 | 6 | 0 | 6 |
| 2021 | 7 | 1 | 8 |
| 2022 | 4 | 0 | 4 |
| 2023 | 4 | 0 | 4 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tuberculosis, Pulmonary" by people in Profiles.
-
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infect Dis. 2024 Feb 21; 24(1):233.
-
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nat Med. 2024 Mar; 30(3):896-904.
-
Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial. Lancet Glob Health. 2023 Dec; 11(12):e1911-e1921.
-
Transrenal Mycobacterium tuberculosis DNA in pulmonary tuberculosis patients during the first 14 days of treatment. Microbiol Spectr. 2023 Dec 12; 11(6):e0234823.
-
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis. Lancet Child Adolesc Health. 2023 05; 7(5):336-346.
-
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.
-
Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 09 06; 9:CD013359.
-
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health. 2022 09; 10(9):e1307-e1316.
-
Abdominal mass with pulmonary nodules in a miliary pattern. Postgrad Med J. 2022 02 01; 98(e1):e49.